Serum-Free Clonal Mesenchymal Stem Cell Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and differentiating mesenchymal stem cells (MSCs) are limited by the need for serum-containing media, which introduces contamination risks and variability, and lack efficient methods for generating MSCs under serum-free conditions, making it difficult to obtain sufficient cells for therapeutic use.
Innovation Solution
A method involving co-culture of primate pluripotent stem cells with OP9 bone marrow stromal cells to express the Apelin receptor, followed by sorting and culturing in semi-solid medium with bFGF to generate mesangioblasts, which are common mesenchymal and endothelial cell precursors, and subsequent isolation of clonal MSC populations in serum-free conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If serum-containing media are used for isolating and differentiating MSCs, then cell proliferation and differentiation are supported, but contamination risks and batch variability increase
Solution Approach 1:
The invention changes the chemical composition parameters of the culture medium by replacing serum-containing media with a defined serum-free medium containing specific growth factors (bFGF at 5-100 ng/ml) and extracellular matrix components. This parameter change eliminates contamination risks associated with serum while maintaining cell proliferation and differentiation through controlled growth factor supplementation.
Solution Approach 2:
The invention extracts and removes the serum component from the culture medium, isolating only the essential growth-promoting factors. By taking out the problematic serum and replacing it with purified, defined components (bFGF, extracellular matrix), the method eliminates contamination risks while preserving the beneficial effects on cell proliferation and differentiation.
2Quantity of substance
If conventional isolation methods from adult tissues are used, then MSCs can be obtained, but sufficient cell numbers for therapeutic use are difficult to obtain
Solution Approach 1:
The invention performs preliminary action by differentiating pluripotent stem cells into mesodermal progenitors before isolation. This pre-differentiation step enriches the culture for MSC precursors, ensuring that when cells are isolated and expanded, sufficient numbers of therapeutic-grade MSCs are obtained without relying on limited adult tissue sources.
Solution Approach 2:
The invention changes the source parameter from adult tissues to pluripotent stem cells, and changes the differentiation state parameter by inducing mesodermal differentiation before isolation. This dual parameter change enables unlimited cell expansion from a single donor while maintaining MSC characteristics, solving both the quantity and ease of manufacture problems.
3Manufacturing precision
If clonal MSC lines are generated, then purity and genetic consistency are improved, but the process requires precise control of differentiation conditions
Solution Approach 1:
The invention changes the differentiation control parameter from multiple complex factors to a simplified system centered on bFGF concentration (5-100 ng/ml) and extracellular matrix composition. This parameter simplification maintains clonal purity and genetic consistency while reducing the complexity of differentiation control requirements.
Solution Approach 2:
The invention introduces extracellular matrix components as an intermediary substrate that mediates the differentiation of pluripotent stem cells into clonal MSC lines. This intermediary provides structural support and biochemical signals that guide differentiation, simplifying the control requirements while ensuring high clonal purity and genetic consistency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the generation of pure clonal MSC lines with high proliferation potential, capable of differentiating into osteogenic, chondrogenic, and adipogenic lineages, while reducing contamination risks and batch variability, and possessing angiogenic potential.
Implementation Method 1
culturing isolated primate pluripotent stem cells in co-culture with OP9 bone marrow stromal cells until Apelin receptor is expressed and detectable in the co-cultured cells
Implementation Method 2
culturing the sorted, Apelin receptor-expressing cells in a serum-free, semi-solid medium containing between about 5 and about 100 ng/ml bFGF until independent colonies form
Implementation Method 3
sorting the co-cultured cells expressing Apelin receptor from cells of the co-culture not expressing Apelin receptor
Implementation Method 4
culturing isolated primate pluripotent stem cells in co-culture with OP9 bone marrow stromal cells
Data Source
Figure 1A
Figure 1B~1C
Figure 1D
AI summary
Methods for obtaining multipotent Apelin receptor-positive lateral plate mesoderm cells, mesenchymal stem cells, and mesangioblasts under serum-free conditions are disclosed.